RegenMed establishes long-term partnerships with its Clients, helping them achieve their objectives through real-world evidence. The Company’s solutions are flexible, minimally burdensome, clinical grade, and scalable. They successfully bridge the interests and environments of multiple stakeholders.
RegenMed delivers sustained return on investment, whether a Client’s goals are clinical, scientific or commercial.
The Obstacles To Value
Different legal environments, revenue models, access to resources, and definitions of “success” divide providers and industry.
However, when industry and providers are able to bridge these differences, patients benefit and medicine advances. If that collaboration is properly designed and executed, all stakeholders generate sustainable value.
The Value of Real-World Evidence
There are over one billion clinician-patient interactions each year in the U.S. Each generates dozens of real-world datapoints. Properly organized, aggregated and analyzed, those data generate real-world evidence.
That real-world evidence can generate substantial value for product manufacturers, distributors, providers, payers, patients and regulators.
Value-based collaboration among clinicians and industry accommodates the operating realities and motivations of each party.
RegenMed solutions address study design, regulatory, product development, clinical burden, IT, patient engagement, financial and other factors key to a successful partnership.
Unlocking The Value of Real-World Evidence
integrate domain expertise, technical infrastructure, collaboration tools, user experience and support processes needed to drive value from real-world evidence.
Circles benefit product manufacturers, distributors, private practices, hospitals, payers, medical societies, foundations and other healthcare stakeholders.